About this episode
Ozempic and other semaglutide drugs have been hailed as a very effective treatment for obesity, but shortages, affordability and doctors’ willingness to prescribe it are still keeping people who might benefit from it off the drug.
Health reporter Carly Weeks explains how the drug works and how it may force our society to rethink how we perceive obesity.
Questions? Comments? Ideas? Email us at [email protected]
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time The Decibel publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Decibel
How much AI music is in your playlist?
The Decibel
What war in Iran means for Canadian oil
The Decibel
Why holding government to account in Ontario could get harder
The Decibel
Behind schedule and over budget: Why do we keep building LRTs?
The Decibel